Vet Med - Czech, 2013, 58(4):187-205 | DOI: 10.17221/6758-VETMED

Carrageenan: a reviewReview

J. Necas, L. Bartosikova
Faculty of Medicine and Dentistry, Palacky University, Olomouc, Czech Republic

Carrageenan is a natural carbohydrate (polysaccharide) obtained from edible red seaweeds. The name Carrageenan is derived from the Chondrus crispus species of seaweed known as Carrageen Moss or Irish Moss in England, and Carraigin in Ireland. Carraigin has been used in Ireland since 400 AD as a gelatin and as a home remedy to cure coughs and colds. It grows along the coasts of North America and Europe. Carrageenans are used in a variety of commercial applications as gelling, thickening, and stabilising agents, especially in food products and sauces. Aside from these functions, carrageenans are used in experimental medicine, pharmaceutical formulations, cosmetics, and industrial applications.

Keywords: carrageenan; pharmacokinetics; toxicity; biological activity

Published: April 30, 2013  Show citation

ACS AIP APA ASA Harvard Chicago IEEE ISO690 MLA NLM Turabian Vancouver
Necas J, Bartosikova L. Carrageenan: a review. CAAS Agricultural Journals. 2013;58(4):187-205. doi: 10.17221/6758-VETMED.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Abraham R, Golberg L, Coulston F (1972): Uptake and storage of degraded carrageenan in lysosomes of reticuloendothelial cells of the rhesus monkey, Macaca mulatta. Experimental and Molecular Pathology 17, 77-93. Go to original source... Go to PubMed...
    2. Abraham R, Benitz KF, Mankes RF, Rosenblum I, Ringwood N (1983): Studies on rhesus monkeys (Macaca mulatta) receiving native carrageenan (Chondrus crispus) orally for 7.5 years. Book 1. Unpublished summary of final report from Institute of Experimental Pathology and Toxicology, Albany Medical College. Submitted to WHO by R.J.H. Gray, International Food Additives Council, Atlanta, Georgia, USA and P. Couchoud, Marinalg, Paris, France.
    3. Anderson W, Soman PD (1966): The absorption of carrageenans. Journal of Pharmacy and Pharmacology 18, 825-827. Go to original source... Go to PubMed...
    4. Arakawa S, Ito M, Tejima S (1988): Promoter function of carrageenan on development of colonic tumours induced by 1,2-dimethylhydrazine in rats. Journal of Nutritional Science and Vitaminology 34, 577-585. Go to original source... Go to PubMed...
    5. Asanza-Teruel ML, Gontier E, Bienaime C, Nava-Saucedo JE, Barbotin JN (1997): Response surface analysis of chlortetracycline and tetracycline production with κ-carrageenan immobilized Streptomyces aureofaciens. Enzyme and Microbial Technology 21, 314-320. Go to original source... Go to PubMed...
    6. Baba M, Snoeck R, Pauwels R, de Clercq E (1988): Sulfated polysaccharides are potent and selective inhibitors of various enveloped viruses, including herpes simplex virus, cytomegalovirus, vesicular stomatitis virus, and human immunodeficiency virus. Antimicrobial Agents and Chemotherapy 32, 1742-1745. Go to original source... Go to PubMed...
    7. Barbeyron T, Michel G, Potin P, Henrissat B, Kloareg B (2000): ι-Carrageenases constitute a novel family of glycoside hydrolases, unrelated to that of κ-carrageenases. Journal of Biological Chemistry 275, 35499-35505. Go to original source... Go to PubMed...
    8. Benitz KF, Golberg L, Coulston F (1973): Intestinal effects of carrageenans in the rhesus monkey (Macaca mulatta). Food and Cosmetic Toxicology 11, 565-575. Go to original source... Go to PubMed...
    9. Botting RM (2000): Mechanism of action of acetaminophen: is there a cyclooxygenase 3? Clinical Infectious Diseases 31, 202-210. Go to original source... Go to PubMed...
    10. Buck ChB, Thompson CD, Roberts JN, Muller M, Lowy DR, Schiller JT (2006): Carrageenan is a potent inhibitor of papillomavirus infection. PLoS Pathogens 2, 0671-0680. Go to original source... Go to PubMed...
    11. Caceres PJ, Carlucci MJ, Damonte EB, Matsuhiro B, Zuniga EA (2000): Carrageenans from chilean samples of Stenogramme interrupta (Phyllophoraceae): structural analysis and biological activity. Phytochemistry 53, 81-86. Go to original source... Go to PubMed...
    12. Carey PL (1958): The digestibility of polysaccharides by rats. [Thesis.] Purdue University. Submitted to WHO by R.J.H. Gray, International Food Additives Council, Atlanta, Georgia, USA, and P. Couchoud, Marinalg, Paris, France.
    13. Carlucci MJ, Pujol CA, Ciancia M, Noseda MD, Matulewicz MC, Damonte EB, Cerezo AS (1997): Antiherpetic and anticoagulant properties of carrageenans from the red seaweed Gigartina skottsbergii and their cyclized derivatives: correlation between structure and biological activity. International Journal of Biological Macromolecules 20, 97-105. Go to original source... Go to PubMed...
    14. Carlucci MJ, Scolaro LA, Damonte EB (1999): Inhibitory action of natural carrageenans on herpes simplex virus infection of mouse astrocytes. Chemotherapy 45, 429-436. Go to original source... Go to PubMed...
    15. Carlucci MJ, Scolaro LA, Noseda MD, Cerezo AS, Damonte EB (2004): Protective effect of a natural carrageenan on genital herpes simplex virus infection in mice. Antiviral Research 64, 137-141. Go to original source...
    16. Cassidy MB, Shaw KW, Lee H, Trevors JT (1997): Enhanced mineralization of pentachlorophenol by kcarrageenan-encapsulated Pseudomonas sp. UG30. Applied Microbiology and Biotechnology 47, 108-113. Go to original source...
    17. Chao YP, Fu H, Lo TE, Chen PT, Wang JJ (1999): Onestep production of D-p-hydroxyphenylglycine by recombinant Escherichia coli strains, Biotechnology Proggress 15, 1039-1045. Go to original source... Go to PubMed...
    18. Chen J, Appleby DW, Weber P, Abraham R (1981): Detection of a carrageenan in rat liver homogenates after feeding in the diet. Toxicologist 1 (Abstr.), 133.
    19. Coulston F, Golberg L, Abraham R, Benitz KF, Ford W (1975): Carrageenans (Hercules Incorporated). Safety evaluation. Nine month study. Unpublished interim progress report from Institute of Comparative and Human Toxicology, Center of Experimental Pathology and Toxicology, Albany Medical College, Albany, New York, USA. Submitted to WHO by R.J.H. Gray, International Food Additives Council, Atlanta, Georgia, USA, and P. Couchoud, Marinalg, Paris, France.
    20. Coulston F, Abraham R, Benitz KF, Ford W (1976): Response of the livers of male and female rats (Osborn/ Mendel and Sprague-Dawley) to Alphacel and a carrageenan (HMR) for nine months using two different basal diets. Nine month progress report from Institute of Comparative and Human Toxicology, Center of Experimental Pathology and Toxicology, Albany Medical College, Albany, New York, USA. Submitted to WHO by R.J.H. Gray, International Food Additives Council, Atlanta, Georgia, USA, and P. Couchoud, Marinalg, Paris, France.
    21. Cuzzocrea S, Sautebin L, De Sarro G, Costantino G, Rombola L, Mazzon E, Lalenti A, De Sarro A, Ciliberto G, Di Rosa M, Caputi AP, Thiemermann CH (1999): Role of IL-6 in the pleurisy and lung injury caused by carrageenan. Journal of Immunology 163, 5094-5104. Go to original source... Go to PubMed...
    22. De SF-Tischer PC, Talarico LB, Noseda MD, Guimaraes SMPB, Damonte EB, Duarte MER (2006): Chemical structure and antiviral activity of carrageenans from Meristiella gelidium against herpes simplex and dengue virus. Carbohydrate Polymers 63, 459-465. Go to original source...
    23. Dewar ET, Maddy ML (1970): Faecal excretion of degraded and native carrageenan by the young rat. Journal of Pharmacy and Pharmacology 22, 791-793. Go to original source... Go to PubMed...
    24. Dos Santos VAPM, Bruijnse M, Tramper J, Wijffels RH (1996a): The magic-bead concept: An integrated approach to nitrogen removal with co-immobilized micro-organisms. Applied Microbiology and Biotechnology 45, 447-453. Go to original source...
    25. Dos Santos VAPM, Tramper J, Wijffels RH (1996b): Dynamic modelling of an integrated nitrogen removal system using Co-immobilized microorganisms Immobilized Cells. Progress in Biotechnology 11, 486- 493. Go to original source...
    26. Eccles R, Meier Ch, Jawad M, Weinmüllner R, Grassauer A, Prieschl-Grassauer E (2010): Efficacy and safety of an antiviral iota-carrageenan nasal spray: a randomized, double-blind, placebo-controlled exploratory study in volunteers with early symptoms of the common cold. Respiratory Research 11, 1-10. Go to original source... Go to PubMed...
    27. Ekstrom LG (1985): Molecular-weight-distribution and the behaviour of kappa-carrageenan on hydrolysis. Part II. Carbohydrate Research 135, 283-289. Go to original source...
    28. Ekstrom LG, Kuivinen J (1983): Molecular weight distribution and hydrolysis behaviour of carrageenans. Carbohydrate Research 116, 89-94. Go to original source...
    29. Elsenhans B, Blume R, Caspary WF (1981): Long-term feeding of unavailable carbohydrate gelling agents. Influence of dietary concentration and microbiological degradation on adaptive responses in the rat. American Journal of Clinical Nutrition 34, 1837-1848. Go to original source... Go to PubMed...
    30. Engster M, Abraham R (1976): Cecal response to different molecular weights and types of carrageenan in the guinea pig. Toxicology and Applied Pharmacology 38, 265-282. Go to original source... Go to PubMed...
    31. Epifanio EC, Veroy RL, Uyenco F, Cajipe GJB, Laserna EC (1981): Carageenan from Eucheuma spiratum in bacteriological media. Applied and Environmental Microbiology 41, 155-163. Go to original source... Go to PubMed...
    32. Estakhr J, Sanchooli N, Najafi SH, Javdan N (2011): Antiinflammatory activity of ethanolic extract of Physalis alkekengi. Research Journal of Pharmaceutical, Biological and Chemical Sciences 2, 421-425.
    33. Food and Drug Research Labs., Inc. (1971): Report on contract No. FDA 71-260 from Food and Drug Research Laboratories, Inc., Maspeth, New York, USA. Submitted to WHO by R.J.H. Gray, International Food Additives Council, Atlanta, Georgia, USA, and P. Couchoud, Marinalg, Paris, France.
    34. Gardin H, Pauss A (2001): Kappa-carrageenan/gelatin gel beads for the co-immobilization of aerobic and anaerobic microbial communities degrading 2,4,6-trichlorophenol under air-limited conditions. Applied Microbiology and Biotechnology 56, 517-523. Go to original source... Go to PubMed...
    35. Gibson GR, Macfarlane S, Cummings JH (1990): The fermentability of polysaccharides by mixed human faecal bacteria in relation to their suitability as bulkforming laxatives. Letters of Applied Microbiology 11, 251-254. Go to original source...
    36. Girond S, Crance JM, Van Cuyck-Gandre H, Renaudet J, Deloince R (1991): Antiviral activity of carrageenan on hepatitis A virus replication in cell culture. Research in Virology 142, 261-270. Go to original source... Go to PubMed...
    37. Gonzalez ME, Alarcon B, Carrasco L (1987): Polysaccharides as antiviral agents: Antiviral activity of carrageenan. Antimicrobial Agents and Chemotherapy 31, 1388-1393. Go to original source... Go to PubMed...
    38. Grassauer A, Weinmuellner R, Meier Ch, Pretsch A, Prieschl-Grassauer E, Unger H (2008): Iota-carrageenan is a potent inhibitor of rhinovirus infection. Virology Journal 5, 1-13. Go to original source... Go to PubMed...
    39. Grasso P, Sharratt M, Carpanini FMB, Gangolli SD (1973): Studies on carrageenan and large-bowel ulceration in mammals. Food and Cosmetics Toxicology 11, 555-564. Go to original source... Go to PubMed...
    40. Guay J, Bateman K, Gordon R, Mancini J, Riendeau D (2004): Carrageenan-induced paw edema in rat elicits a predominant prostaglandin E2 (PGE2) response in the central nervous system associated with the induction of microsomal PGE2 synthase-1. Journal of Biological Chemistry 279, 24866-24872. Go to original source... Go to PubMed...
    41. Hagiwara A, Miyashita K, Nakanishi T, Sano M, Tamano S, Asai I, Nakamura M, Imaida K, Ito N, Shirai T (2001): Lack of tumor promoting effects of carrageenan on 1,2-dimethylhydrazine-induced colorectal carcinogenesis in male F344 rats. Journal of Toxicology and Pathology 14, 37-43. Go to original source...
    42. Handy RLC, Moore PK (1998): A comparison of the effects of L-NAME, 7-NI and L-NIL on carrageenaninduced hindpaw oedema and NOS activity. British Journal of Pharmacology 123, 1119-1126. Go to original source... Go to PubMed...
    43. Hawkins WW, Yaphe W (1965): Carrageenan as a dietary constituent for the rat: Faecal excretion, nitrogen absorption, and growth. Canadian Journal of Biochemistry and Physiology 43, 479-484. Go to original source... Go to PubMed...
    44. Henriques MGMO, Silva PMR, Martins MA, Flores CA, Cunha FQ, Assreuy-Filho J, Cordeiro RSB (1987): Mouse paw oedema. A new model for inflammation? Brazilian Journal of Medical and Biological Research 20, 243-249.
    45. International Food Additives Council (1997): Unpublished monograph prepared by the International Food Additives Council, Washington DC. Submitted to WHO by R.J.H. Gray, International Food Additives Council, Atlanta, Georgia, USA, and P. Couchoud, Marinalg, Paris, France.
    46. Jain NK, Patil CS, Singh A, Kulkarni SK (2001): A simple technique to evaluate inflammatory pain along with anti-inflammatory studies in carrageenan-induced paw edema. Indian Journal of Pharmacology 33, 114- 115.
    47. JECFA (1974): Toxicological evaluation of certain food additives with a review of general principles and of specifications. Seventeenth report of the Joint FAO/ WHO Expert Committee on Food Additives. FAO Nutrition Meetings Series, No.53. WHO Technical Report Series, No.539 and corrigendum. World Health Organization, Geneva.
    48. Kindness G, Long WF, Williamson FB (1979): Enhancement of antithrombin III activity by carrageenans. Thrombosis Research 15, 49-60. Go to original source... Go to PubMed...
    49. Kindness G, Long WF, Williamson FB (1980a): Anticoagulant effects of sulphated polysaccharides in normal and antithrombin III-deficient plasmas. British Journal of Pharmacology 69, 675-677. Go to original source... Go to PubMed...
    50. Kindness G, Williamson FB, Long WF (1980b): Involvement of antithrombin III in anticoagulant effects of sulphated polysaccharides. Biochemical Society Transactions 8, 82-83. Go to original source... Go to PubMed...
    51. Krishnan MS, Nghiem NP, Davison BH (1999): Ethanol production from corn starch in a fluidized-bed bioreactor. Applied Biochemistry and Biotechnology 77-79, 359-371. Go to original source... Go to PubMed...
    52. Lai VMF, Wong PA-L, Lii C-Y (2000): Effects of cation properties on sol-gel transition and gel properties of κ-carrageenan. Journal of Food Science 65, 1332-1337. Go to original source...
    53. Leibbrandt A, Meier Ch, Konig-Schuster M, Weinmullner R, Kalthoff D, Pflugfelder B, Graf P, Frank-Gehrke B, Beer M, Fazekas T, Unger H, Prieschl-Grassauer E, Grassauer A (2010): Iota-carrageenan is a potent inhibitor of influenza a virus infection. PLoS ONE 5, 1-12. Go to original source... Go to PubMed...
    54. Lynch G, Low L, Li S, Sloane A, Adams S, Parish C, Kemp B, Cunningham AL (1994): Sulfated polyanions prevent HIV infection of lymphocytes by disruption of the CD4-gp120 interaction, but do not inhibit monocyte infection. Journal of Leukocyte Biology 56, 266-272. Go to original source... Go to PubMed...
    55. Mallett AK, Wise A, Rowland IR (1984): Hydrocolloid food additives and rat caecal microbial enzyme activities. Food and Chemical Toxicology 22, 415-418. Go to original source... Go to PubMed...
    56. Mallett AK, Rowland IR, Bearne CA, Nicklin S (1985): Influence of dietary carrageenans on microbial biotransformation activities in the cecum of rodents and on gastrointestinal imine status in the rat. Toxicology and Applied Pharmacology 78, 377-385. Go to original source... Go to PubMed...
    57. Mankes R, Abraham R (1975): Lysosomal dysfunction in colonic submucosal macrophages of rhesus monkeys caused by degraded iota carrageenan. Proceedings of the Society for Experimental Biology and Medicine 150, 166-170. Go to original source... Go to PubMed...
    58. Marchetti M, Pisani S, Pietropaolo V, Seganti L, Nicoletti R, Orsi N (1995): Inhibition of herpes simplex virus infection by negatively charged and neutral carbohydrate polymers. Journal of Chemotherapy 7, 90-96. Go to original source... Go to PubMed...
    59. McGill HC Jr, McMahan CA, Wigodsky HS, Sprinz H. (1977): Carrageenan in formula and infant baboon development. Gastroenterology 73, 512-517. Go to original source...
    60. Mensour NA, Margaritis A, Briens CL, Pilkington H, Russel I (1996): Application of immobilized yeast cells in the brewing industry. Progress in Biotechnology 11, 661-671. Go to original source...
    61. Mensour NA, Margaritis A, Briens CL, Pilkington H, Russell I (1997): New developments in the brewing industry using immobilised yeast cell bioreactor systems. Journal of the Institute of Brewing 103, 363-370. Go to original source...
    62. Michel A-S, Mestdagh MM, Axelos MAV (1997): Physico-chemical properties of carrageenan gels in presence of various cations. International Journal of Biological Macromolecules 21, 195-200. Go to original source... Go to PubMed...
    63. Morard JC, Fray A, Abadie A, Robert L (1964): Nature of the renal lesions induced by intravenous injection of carrageenan. Nature 202, 401-402. Go to original source... Go to PubMed...
    64. Mori A (1993): Industrial Application of Immobilized Biocatalysts. Tanaka A, Tosa T, Kobayashi T (eds.): Marcel Dekker Inc., New York. 291-313.
    65. Nagalakshmi V, Pai JS (1997): Immobilisation of penicillin acylase producing E.coli cells with κ-carrageenan. Indian Journal of Microbiology 37, 17-20.
    66. Nantel F, Denis D, Gordon R, Northey A, Cirino M, Metters KM, Chan ChCh (1999): Distribution and regulation of cyclooxygenase-2 in carrageenan-induced inflammation. British Journal of Pharmacology 28, 853-859. Go to original source... Go to PubMed...
    67. Naude PJ, Cromarty AD, van Rensburg CE (2010): Potassium humate inhibits carrageenan-induced paw oedema and a graft-versus-host reaction in rats. Inflammopharmacology, 18, 33-39. Go to original source... Go to PubMed...
    68. Nicklin S, Miller K (1984): Effect of orally administered food-grade carrageenans on antibody-mediated and cell-mediated immunity in the inbred rat. Food and Chemical Toxicology 22, 615-621. Go to original source... Go to PubMed...
    69. Nicklin S, Baker K, Miller K (1988): Intestinal uptake of carrageenan: Distribution and effects on humoral immune competence. Advances in Experimental Medicine and Biology 237, 813-820. Go to original source... Go to PubMed...
    70. Nigam JN (2000): Continuous ethanol production from pineapple cannery waste using immobilized yeast cells. Journal of Biotechnology 80, 189-193. Go to original source... Go to PubMed...
    71. Nilson HW, Schaller JW (1941): Nutritive value of agar and Irish moss. Food Research 6, 461-469. Go to original source...
    72. Nilson HW, Wagner JA (1959): Feeding test with carrageenin. Food Research 24, 235-239. Go to original source...
    73. Norton S, Watson K, D'Amore T (1995): Ethanol tolerance of immobilized brewers' yeast cells. Applied Microbiology and Biotechnology 43, 18-24. Go to original source... Go to PubMed...
    74. Ochuba GU, von Riesen VL (1980): Fermentation of polysaccharides by Klebsiellae and other facultative bacteria. Applied and Environmental Microbiology 39, 988-992. Go to original source... Go to PubMed...
    75. Omote K, Hazama K, Kawamata T, Kawamata M, Nakayaka Y, Toriyabe M, Namiki A (2001): Peripheral nitric oxide in carrageenan-induced inflammation. Brain Research 912, 171-175. Go to original source... Go to PubMed...
    76. Osuga J, Mori A, Kato J (1984): Acetic acid production by immobilized Acetobacter aceti cells entrapped in a κ-carrageenan gel. Journal of Fermentation Technology 62, 139-149.
    77. Panlasigui LN, Baello OQ, Dimatangal JM, Dumelod DB (2003): Blood cholesterol and lipid-lowering effects of carrageenan on human volunteers. Asia Pacific Journal of Clinical Nutrition 12, 209-214.
    78. Paschapur MS, Patil MB, Kumar R, Patil SR (2009): Evaluation of anti-inflammatory activity of ethanolic extract of Borassus flabellifer L. male flowers (inflorescences) in experimental animals. Journal of Medicinal Plants Research 2, 49-54.
    79. Petersson M, Wiberg U, Lundeberg T, Uvnas-Moberg K (2001): Oxytocin decreases carrageenan induced inflammation in rats. Peptides 22, 1479-1484. Go to original source... Go to PubMed...
    80. Pittman KA, Golberg L, Coulston F (1976): Carrageenan: The effect of molecular weight and polymer type on its uptake, excretion and degradation in animals. Food and Cosmetics Toxicology 14, 85-93. Go to original source... Go to PubMed...
    81. Porto GG, Vasconcelos BC, Silva-Junior VA, Souza Andrade ES (2010): The use of carrageenan for limiting the mandibular movement in rats: A preliminary experimental study. Medicina Oral, Patologia Oral y Cirugia Bucal 15, 653-657. Go to original source... Go to PubMed...
    82. Posadas I, Bucci M, Roviezzo F, Rossi A, Parente L, Sautebin L, Cirino G (2004): Carrageenan-induced mouse paw oedema is biphasic, age-weight dependent and displays differential nitric oxide cyclooxygenase-2 expression. British Journal of Pharmacology 142, 331-338. Go to original source... Go to PubMed...
    83. Poulsen E (1973): Short-term peroral toxicity of undegraded carrageenan in pigs. Food and Cosmetics Toxicology 11, 219-227. Go to original source... Go to PubMed...
    84. Poupin P, Mazure N, Truffaut N (1996): Morpholine degradation by strain Mycobacterium aurum MOI : Improvement of cells growth and morpholine degradation rate by cells immobilization. Progress in Biotechnology 11, 770-776. Go to original source...
    85. Radhakrishnan R, Bement MKH, Skyba D, Sluka KA (2004): Models of muscle pain: carrageenan model and acidic saline model. Current Protocols in Pharmacology 25, 1-28. Go to original source... Go to PubMed...
    86. Reddy BS, Watanabe K, Sheinfil A (1980): Effect of dietary wheat bran, alfalfa, pectin and carrageenan on plasma cholesterol and fecal bile acid and neutral sterol excretion in rats. Journal of Nutrition 110, 1247-1254. Go to original source... Go to PubMed...
    87. Robbins MC (1997): A 90-day feeding study in the rat with semi-refined carrageenan from two sources, including a recovery phase. Unpublished report of project No. 3160/1/2/97 from BIBRA International, Carshalton, Surrey, United Kingdom. Submitted to WHO by Dr H.J. Bixler, Seaweed Industry Association of the Philippines, Searsport, Maine, USA.
    88. Rocha de Souza MC, Marques CT, Dore CMG, da Silva FRF, Rocha HAO, Leite EL (2007): Antioxidant activities of sulfated polysaccharides from brown and red seaweeds. Journal of Applied Phycology 19, 153-160. Go to original source... Go to PubMed...
    89. Rosen A, Lundeberg T, Bytner B, Nylander I (2000): Central changes in nociceptin dynorphin B and Met-enkephalin-Arg-Phe in different models of nociception. Brain Research 857, 212-218. Go to original source... Go to PubMed...
    90. Rustia M, Shubik P, Patil K (1980): Lifespan carcinogenicity tests with native carrageenan in rats and hamsters. Cancer Letters 11, 1-10. Go to original source... Go to PubMed...
    91. Salvemini D, Wang S-Q, Wyatt PS, Bourdon DM, Marino MH, Manning PT, Currie MG (1996): Nitric oxide: a key mediator in the early and late phase of carrageenan-induced rat paw inflammation. British Journal of Pharmacology 118, 829-838. Go to original source... Go to PubMed...
    92. Salyers AA, West SEH, Vercellotti JR, Wilkins TD (1977): Fermentation of mucins and plant polysaccharides by anaerobic bacteria from the human colon. Applied and Environmental Microbiology 34, 529-533. Go to original source... Go to PubMed...
    93. SCF (1978): Reports of the Scientific Committee for Food. Seventh series. Commission of the European Communities, Luxembourg.
    94. Shanmugam M, Mody KH (2000): Heparinoid-active sulphated polysaccharides from marine algae as potential blood anticoagulant agents. Current Science 79, 1672-1683.
    95. Sharratt M, Grasso P, Carpanini F, Gangolli SD (1970): Carrageenan ulceration as a model for human ulcerative colitis. Lancet 297, 192-193. Go to original source... Go to PubMed...
    96. Silva FRF, Dore CMPG, Marques CT, Nascimento MS, Benevides NMB, Rocha HAO, Chavante SF, Leite EL (2010): Anticoagulant activity, paw edema and pleurisy induced carrageenan: Action of major types of commercial carrageenans. Carbohydrate Polymers 79, 26-33. Go to original source...
    97. Sini JM, Yaro AH, Ayanwuyi LO, Aiyelero OM, Mallum SM, Gamaniel KS (2010): Antinociceptive and antiinflammatory activities of the aqueous extract of the root bark of Combretumsericeum in rodents. African Journal of Biotechnology 9, 8872-8876.
    98. Sodini I, Boquien CY, Corrieu G, Lacroix C (1997a): Use of an immobilized cell bioreactor for the continuous inoculation of milk in fresh cheese manufacturing. Journal of Industrial Microbiology and Biotechnology 18, 56-61. Go to original source... Go to PubMed...
    99. Sodini I, Boquien CY, Corrieu G, Lacroix C (1997b): Microbial dynamics of co- and separately entrapped mixed cultures of mesophilic lactic acid bacteria during the continuous prefermentation of milk. Enzyme and Microbial Technology 20, 381-388. Go to original source... Go to PubMed...
    100. Stancioff DJ, Renn DW (1975): Physiological effects of carrageenan. American Cancer Society Symposium Series 15, 1-12. Go to original source...
    101. Stanley N (2011): FAO Corporate document repository. Chapter 3: Production, properties and uses of carrageenan. FMC Corporation, Marine Colloids Division 5 Maple Street, Rockland Maine 04841, USA.
    102. Stiles J, Guptill-Yoran L, Moore GE, Pogranichniy RM (2008): Effects of κ-carrageenan on in vitro replication of feline herpesvirus and on experimentally induced herpetic conjunctivitis in cats. Investigative Ophthalmology and Visual Science 49, 1496-1501. Go to original source... Go to PubMed...
    103. Sugishita E, Amagaya S, Ogihara Y (1981): Antiinflammatory testing methods: comparative evaluation of mice and rats. Journal of Pharmacobio-Dynamics 8, 565-575. Go to original source... Go to PubMed...
    104. Swain A, Waterhouse KV, Venables WA, Callely AG, Lowe SE (1991): Biochemical studies of morpholine catabolism by an environmental mycobacterium. Applied Microbiology and Biotechnology 35(1), 110-114. Go to original source...
    105. Takamatsu, S, Tosa T (1993): Production of L-alanine and D-aspartic acid. Bioprocess Technology 16, 25-35.
    106. Tobacman JK (2001): Review of harmful gastrointestinal effects of carrageenan in animal experiments. Environmental Health Perspectives 109, 983-994. Go to original source... Go to PubMed...
    107. Tobacman JK, Wallace RB, Zimmerman MB (2001): Consumption of carrageenan and other water-soluble polymers used as food additives and incidence of mammary carcinoma. Medical Hypotheses 58, 589-598. Go to original source... Go to PubMed...
    108. Tomarelli RM, Tucker WD Jr, Bauman LM, Savini S, Weaber JR (1974): Nutritional qualities of processed milk containing carrageenan. Journal of Agricultural and Food Chemistry 22, 819-824. Go to original source... Go to PubMed...
    109. Tosa T, Shibatani T (1995): Industrial Application of Immobilized Biocatalysts in Japan. Annals of New York Academy of Sciences 750, 364-375. Go to original source... Go to PubMed...
    110. Udall JN, Harmatz P, Vachino G, Galdabini J, Walker WA (1981): Intestinal transport and liver uptake of a food additive present in infant formulas (Abstract). Pediatric Research 15, 549. Go to original source...
    111. Van de Velde F, Lourenco ND, Pinheiro HM, Bakkerd M (2002): Carrageenan: a food-grade and biocompatible support for immobilisation techniques. Advanced Synthesis and Catalysis 344, 815-835. Go to original source...
    112. Wang JL, Li P, Shi H, Qian Y (1997): Immobilization of microorganisms using carrageenan gels coated with chitosan and application to biodegradation of 4-chlorophenol. Journal of Environmental Sciences 9, 283-287.
    113. Watt J, Marcus R (1969): Ulcerative colitis in the guineapig caused by seaweed extract. Journal of Pharmacy and Pharmacology 21, 187S-188S. Go to original source... Go to PubMed...
    114. Watt J, Marcus R (1971): Carrageenan-induced ulceration of the large intestine in the guinea pig. Gut 12, 164-171. Go to original source... Go to PubMed...
    115. Weiner ML (1991): Toxicological properties of carrageenan. Agents Actions 32, 46-51. Go to original source... Go to PubMed...
    116. Wijesekara I, Pangestuti R, Kim SK (2011): Biological activities and potential health benefits of sulfated polysaccharides derived from marine algae. Carbohydrate Polymers 84, 14-21. Go to original source...
    117. Witvrouw M, De Clercq E (1997): Sulfated polysaccharides extracted from sea algae as potential antiviral drugs. General Pharmacology 29, 497-511. Go to original source... Go to PubMed...
    118. Wunderwald P, Schrenk WJ, Port H (1979): Antithrombin BM from human plasma: an antithrombin binding moderately to heparin. Thrombosis Research 15, 49-60.
    119. Yamamoto I, Maruyama H, Takahashi M, Komiyama K (1986): The effect of dietary or intraperitoneally injected seaweed preparations on the growth of sarcoma-180 cells subcutaneously implanted into mice. Cancer Letters 30, 125-131. Go to original source... Go to PubMed...
    120. Yuan H, Song J (2005): Preparation, structural characterization and in vitro antitumor activity of kappa-carrageenan oligosaccharide fraction from Kappaphycus striatum. Journal of Applied Phycology 17, 7-13. Go to original source...
    121. Yuan H, Song J, Li X, Li N, Dai J (2004): Immunomodulation and antitumor activity of κ-carrageenan Oligosaccharides. Pharmacological Research 50, 47-53.
    122. Yuan H, Song J, Li X, Li N, Dai J (2006): Immunomodulation and antitumor activity of κ-carrageenan oligosaccharides. Cancer Letters 243, 228-234. Go to original source... Go to PubMed...
    123. Zacharopoulos VR, Phillips DM (1997): Vaginal formulations of carrageenan protect mice from herpes simplex virus infection. Clinical and Diagnostic Laboratory Immunology 4, 465-468. Go to original source... Go to PubMed...
    124. Zeitlin L, Whaley KJ, Hegarty TA, Moench TR, Cone RA (1997): Tests of vaginal microbicides in the mouse genital herpes model. Contraception 56, 329-335. Go to original source... Go to PubMed...
    125. Zhou G, Sheng W, Yao W, Wang Ch (2006): Effect of low molecular-carrageenan from Chondrus ocellatus on antitumor H-22 activity of 5-Fu. Pharmacological Research 53, 129-134. Go to original source... Go to PubMed...
    126. Zhou G, Sun YP, Xin X, Zhang Y, Li L, Xu Z (2004): In vivo antitumor and immunomodulation activities of different molecular weight lambda-carrageenans from Chondrus ocellatus. Pharmacological Research 50, 47-53. Go to original source... Go to PubMed...

    This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International (CC BY NC 4.0), which permits non-comercial use, distribution, and reproduction in any medium, provided the original publication is properly cited. No use, distribution or reproduction is permitted which does not comply with these terms.


    Return to the content